UNSPSC 51111905: Porfimer sodium
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51111900
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51111905
| NIGP code |
|---|
| 26910 Antineoplastic Agents |
Definition
This classification denotes a photosensitizing agent with the molecular formula (C34H35N4NaO5)n.(C34H33N4NaO4)n, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3834SIK5F, chemically known as 21h,23h-porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21h,23h-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl- but generally known as porfimer sodium, which bears US NIH Compound Identifier 57166.
Read the full definition
European Medicines Agency schedules Porfimer sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03955MIG. The term PORFIMER SODIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules porfimer sodium in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule porfimer sodium under HS 38249064 and SITC 59899. As of Q4 2014, PORFIMER SODIUM remains the US FDA Preferred Term for this commodity.
Porfimer sodium bears US NLM identifiers UMLS ID C0058031 and NCI Concept Code C1071. SMILES: CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O.
About UNSPSC 51111905
UNSPSC 51111905 Porfimer sodium is a Commodity code that classifies pharmaceutical products — specifically the photosensitizing agent porfimer sodium used in photodynamic therapy for certain cancers. State and local governments procure this drug primarily through health department pharmacy programs, Medicaid agencies, and public hospital systems that treat eligible patient populations. The Texas Health and Human Services Commission, as evidenced by its April 2026 RFI on direct-to-manufacturer prescription programs, represents the primary issuing body type under this code — state health agencies and Medicaid programs managing pharmacy benefit procurement and seeking to optimize drug sourcing channels outside traditional pharmacy benefit manager and group purchasing organization arrangements.
Recent activity centers on Texas, where the HHS Commission issued RFI No. HHS0017013 on March 27, 2026 (response deadline April 3, 2026) to gather vendor capabilities for implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. This RFI seeks information from vendors regarding their experience with direct contracting for self-insured employers and health plans, flexibility to negotiate contracts based on negotiated net pricing models without rebates, and capability to implement value-based or outcomes-based agreements. The RFI is exploratory in nature — designed to inform the state's future procurement strategy before issuing a formal RFP — and does not specify award values, budget allocations, set-aside designations, or incumbent contractor information at this stage.
Quick answers
What is UNSPSC 51111905?
UNSPSC 51111905 is Porfimer sodium, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51111905?
UNSPSC 51111905 maps to 1 NIGP code, 26910 Antineoplastic Agents.
On GovTribe
See everything under UNSPSC 51111905
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code